AMBICALE — 1832181
Application number
1832181
Registration number
TMA1037821
Type(s)
Word
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2017-04-11
Registered
2019-07-08
Registration Expiry Date
2029-07-08
Current owner
Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.)
Rechenstrasse 37
9014 St. Gallen
SWITZERLAND
Agent
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREET
OTTAWA
ONTARIO K1P1C3
Registered Owner
Vifor Pharma, Inc.
1000 First Avenue, Suite 300,
King of Prussia, PA 19406
UNITED STATES OF AMERICA
Applicant
Vifor Pharma, Inc.
1000 First Avenue, Suite 300,
King of Prussia, PA 19406
UNITED STATES OF AMERICA
Documents
Index headings
- AMBICALE
Goods (Nice class & Statement)
- (1) Pharmaceutical preparations for the treatment and prevention of hyperkalemia; pharmaceutical preparations for the treatment and prevention of renal, cardiovascular, gastrointestinal and hyperkalemia-associated endocrine diseases and disorders; pharmaceutical preparations for reducing potassium levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and hyperkalemia-associated endocrine disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and hyperkalemia-associated endocrine disorders
Classification data
Disclaimer
The classification data is provided for information and searching purposes only. CIPO does not warrant the accuracy of the classes assigned to the trademark. This data has no legal value of any kind.
- 5 - Pharmaceuticals and herbicides
Claims
- Proposed Use in CANADA
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Name / Nom DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2025-08-21 DATE OF CHANGE / DATE DE CHANGEMENT: 2021-01-28 COMMENTS / COMMENTAIRES: FROM: Relypsa, Inc. TO: Vifor Pharma, Inc. Voir Preuve au dossier/See evidence on File No. 1832181 Owner Address Change / Changement d'adresse du propriétaire DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2025-08-21 COMMENTS / COMMENTAIRES: Voir Preuve au dossier/See evidence on File No. 1832181 CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Assignment / Cession DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2025-08-21 DATE OF CHANGE / DATE DE CHANGEMENT: 2025-06-03 COMMENTS / COMMENTAIRES: FROM: Vifor Pharma, Inc. TO: Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.) Voir Preuve au dossier/See evidence on File No. 1832181Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2017-04-11 | ||
| Created | 2017-04-12 | ||
| Formalized | 2017-04-18 | ||
| Search Recorded | 2018-04-03 | ||
| Examiner's First Report | 2018-04-03 | 2018-10-03 | |
| Approval Notice Sent | 2018-11-27 | 2018-12-25 | |
| Approved | 2019-01-17 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2019-02-06 | Vol.66 Issue 3354 | |
| Allowed | 2019-05-24 | ||
| Allowance Notice Sent | 2019-05-24 | 2020-04-11 | |
| Registered | 2019-07-08 | 2029-07-08 | |
| Agent Changed | 2025-08-21 | From: 9681 To: 8390 / Voir Preuve au dossier/See evidence on File No. 1832181 | |
| Amendment to Registration | 2025-08-21 | Name / Voir Preuve au dossier/See evidence on File No. 1832181 | |
| Amendment to Registration | 2025-08-21 | Owner Address Change / Voir Preuve au dossier/See evidence on File No. 1832181 | |
| Change of Title Registered | 2025-08-21 | Assignment / Voir Preuve au dossier/See evidence on File No. 1832181 |